期刊
ONCOLOGY LETTERS
卷 26, 期 4, 页码 -出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/ol.2023.14020
关键词
spinal cord; central nervous system; primary melanoma; radiotherapy; chemotherapy; bevacizumab
类别
CNS malignant melanomas are rare tumors that arise from abnormal changes in melanocytes during embryonic development. Few cases of primary malignant melanoma in the spinal canal have been reported. This study presents a rare case of primary malignant melanoma in the thoracic spinal canal, with an incompletely resected tumor. The patient achieved disease-free survival of over 2.5 years after treatment with chemoradiotherapy and adjuvant chemotherapy.
Central nervous system (CNS) malignant melanomas are rare tumors of the CNS that are thought to arise from aberrant changes in melanocytes of the neural crest or melanocytic elements of the pia mater during early embryonic development. As a rare type of CNS malignant melanoma, only a few cases of primary malignant melanoma in the spinal canal have been reported thus far. The majority of these studies have reported on the diagnosis, radiographic features and gross total resection of primary spinal canal malignant melanoma; however, the prognosis and ideal treatment of patients with residual tumors remain elusive. The current study presented the rare case of a patient with primary malignant melanoma originating from the thoracic spinal canal, without any history of irradiation exposure and with an incompletely resected tumor. Disease-free survival of >2.5 years was observed in this patient who was treated with concurrent chemoradiotherapy followed by adjuvant chemotherapy with temozolomide and bevacizumab.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据